Stemline Therapeutics Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Stemline Therapeutics Reports Second Quarter 2015 Financial Results

Stemline Therapeutics (STML) Misses Q2 EPS by 17c

August 10, 2015 5:08 PM EDT

Stemline Therapeutics (NASDAQ: STML) reported Q2 EPS of ($0.58), $0.17 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Stemline Therapeutics (STML) click here.

... More